Navigating the Challenges of Evidence-based Chronic Kidney Disease Care
preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney, Kidney Int, 2009;76:1192–8.
37. Chapin E, Zhan M, Hsu VD, et al., Adverse Safety Events in Chronic Kidney Disease: The frequency of "multiple hits," Clin J Am Soc Nephrol, 2010;5:95–101.
38. Plantinga L, Grubbs V, Sarkar U, et al., For the CDC CKD Surveillance Team, Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United States, Ann Fam Med, 2011;9:423–30.
39. Stevens LA, Richardson MM, Feldman HI, et al., Comparison of Drug Dosing Recommendations Based on Measured GFR and Kidney Function Estimating Equations, Am J Kidney Dis, 2009;54:33–42.
40. Kagoma YK, Weir MA, Iansavichus AV, et al., Impact of Estimated GFR Reporting on Patients, Clinicians, and Health-Care Systems: A Systematic Review, Am J Kidney Dis, 2011;57:592–601.
41. Kim KH, Fonda JR, Lawler EV, et al., Change in use of gadolinium- enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross- sectional study of Veterans Affairs Health Care System data from 2005-2008, Am J Kidney Dis, 2010;56:438–67.
42. National Kidney Foundation: KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification, Am J Kidney Dis, 2002;39(Suppl. 1):S1–S266.
43. Vassalotti JA, Stevens LA, Levey AS, Testing for Chronic Kidney
Disease: A position statement from the National Kidney Foundation, Am J Kidney Dis, 2007;50:169–80.
44. Boulware LE, Troll MU, Jarr BG, et al., Identification and referral of patients with progressive CKD: a national study, Am J Kidney Dis, 2006;48:192–204.
45. Fox CH, Brooks A, Zayas LE, et al., Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study, J Am Board Fam Med, 2006;19:54–61.
46. Kinchen KS, Sadler J, Fink N, et al., The timing of specialist evaluation in chronic kidney disease and mortality, Ann Intern Med, 2002;137:479–86.
47. Chan MR, Dall AT, Fletcher KE, et al., Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta- analysis, Am J Med, 2007;120:1063–70.
48. Winkelmayer WC, Liu J, Chertow GM, Tamura MK, Predialysis Nephrology Care of Older Patients Approaching End-Stage Renal Disease, Arch Intern Med, 2011;171:1371–8.
49. U.S. Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
50. Copper BA, Branley P, Bulfone L, et al., A randomized, controlled trial of early versus late initiation of dialysis, N Engl J Med,
2010;363:606–19.
51. Rostansky SJ, Eggers P, Jackson K, et al., Early Start of Hemodialysis May Be Harmful, Arch Intern Med, 2011;171:396–403.
52. Osherhoff JA, Teich JM, Middleton B, et al., A Roadmap for National Action on Clinical Decision Support, J Am Med Inform Assoc, 2007;14:141–5.
53. Patwardhan MB, Kawamoto K, Lobach D, et al., Recommendations for Clinical Decision Support for the Management of Individuals with Chronic Kidney Disease, Clin J Am Soc Nephrol, 2009;4:273–83.
54. Rutkowski M, Mann W, Derose S, et al., Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente, Am J Kidney Dis, 2009;53(3 Suppl. 3):S86–99.
55. Wyatt C, Konduri V, Eng J, Rohatgi R, Reporting of estimated GFR in the primary care clinic, Am J Kidney Dis, 2007;49:634–41.
56. Patel TG, Pogach LM, Barth RH, CKD screening and management in the Veterans Health Administration: the impact of system organization and an innovative electronic record, Am J Kidney Dis, 2009;53(3 Suppl. 3):S78–85.
57. Hartzband P, Groopman J, Off the record—avoiding the pitfalls of going electronic, N Engl J Med, 2008;358:1656–8.
58. Sadler JH, With the pursuit of quality comes a retreat from personal care: the path of medical practice and dialysis care in America, Am J Kidney Dis, 2007;50:535–7.
US NEPHROLOGY
79
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84